Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neovascularization, Physiologic | 4 | 2019 | 73 | 2.380 |
Why?
|
| Exosomes | 5 | 2021 | 101 | 2.220 |
Why?
|
| MicroRNAs | 6 | 2021 | 426 | 1.850 |
Why?
|
| Myocardial Ischemia | 2 | 2018 | 75 | 1.180 |
Why?
|
| Adipose Tissue | 2 | 2017 | 177 | 1.020 |
Why?
|
| Stem Cells | 4 | 2021 | 141 | 1.000 |
Why?
|
| Ischemia | 2 | 2020 | 46 | 0.850 |
Why?
|
| Repressor Proteins | 3 | 2013 | 249 | 0.790 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2016 | 130 | 0.770 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2016 | 86 | 0.760 |
Why?
|
| Carotid Arteries | 2 | 2016 | 28 | 0.690 |
Why?
|
| Nerve Tissue Proteins | 2 | 2016 | 360 | 0.680 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 37 | 0.680 |
Why?
|
| Heart | 2 | 2018 | 180 | 0.670 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 225 | 0.660 |
Why?
|
| Endothelial Cells | 2 | 2021 | 308 | 0.590 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 282 | 0.590 |
Why?
|
| Dermatitis, Irritant | 1 | 2016 | 1 | 0.580 |
Why?
|
| Diclofenac | 1 | 2016 | 2 | 0.580 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2016 | 5 | 0.580 |
Why?
|
| G1 Phase | 2 | 2016 | 33 | 0.570 |
Why?
|
| Menthol | 1 | 2016 | 21 | 0.570 |
Why?
|
| Wound Healing | 1 | 2017 | 70 | 0.560 |
Why?
|
| Adult Stem Cells | 1 | 2016 | 12 | 0.550 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2016 | 31 | 0.550 |
Why?
|
| S Phase | 1 | 2016 | 37 | 0.540 |
Why?
|
| Skin | 1 | 2016 | 174 | 0.520 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 132 | 0.510 |
Why?
|
| Adipocytes | 2 | 2013 | 58 | 0.510 |
Why?
|
| Brain Ischemia | 1 | 2017 | 184 | 0.510 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 123 | 0.500 |
Why?
|
| Animals | 12 | 2021 | 15081 | 0.470 |
Why?
|
| Adipogenesis | 1 | 2013 | 12 | 0.470 |
Why?
|
| Mitochondria | 3 | 2013 | 487 | 0.460 |
Why?
|
| Transcription Factors | 1 | 2016 | 681 | 0.390 |
Why?
|
| Cells, Cultured | 6 | 2016 | 1518 | 0.380 |
Why?
|
| Hindlimb | 2 | 2020 | 27 | 0.350 |
Why?
|
| Rats | 6 | 2017 | 3483 | 0.320 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2021 | 84 | 0.320 |
Why?
|
| Stem Cell Transplantation | 2 | 2018 | 31 | 0.310 |
Why?
|
| Cell Movement | 3 | 2019 | 571 | 0.290 |
Why?
|
| Mice | 4 | 2021 | 5913 | 0.290 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1015 | 0.280 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2019 | 1618 | 0.270 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2006 | 46 | 0.260 |
Why?
|
| Obesity | 1 | 2013 | 1067 | 0.260 |
Why?
|
| Up-Regulation | 3 | 2016 | 513 | 0.220 |
Why?
|
| Cell Line | 2 | 2019 | 1354 | 0.210 |
Why?
|
| Receptors, Immunologic | 2 | 2016 | 61 | 0.200 |
Why?
|
| Humans | 13 | 2018 | 37093 | 0.190 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2016 | 98 | 0.190 |
Why?
|
| Male | 6 | 2019 | 20025 | 0.180 |
Why?
|
| Reactive Oxygen Species | 2 | 2013 | 461 | 0.180 |
Why?
|
| Angiogenic Proteins | 1 | 2019 | 7 | 0.180 |
Why?
|
| Regional Blood Flow | 1 | 2019 | 40 | 0.170 |
Why?
|
| Cell Differentiation | 2 | 2013 | 587 | 0.170 |
Why?
|
| Gene Silencing | 2 | 2012 | 151 | 0.170 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2018 | 9 | 0.170 |
Why?
|
| Recovery of Function | 1 | 2019 | 88 | 0.170 |
Why?
|
| Caspase 3 | 2 | 2016 | 207 | 0.150 |
Why?
|
| Antipruritics | 1 | 2016 | 2 | 0.150 |
Why?
|
| Administration, Cutaneous | 1 | 2016 | 43 | 0.140 |
Why?
|
| Gels | 1 | 2016 | 42 | 0.140 |
Why?
|
| Drug Combinations | 1 | 2016 | 98 | 0.140 |
Why?
|
| Macrophages | 1 | 2020 | 439 | 0.140 |
Why?
|
| E2F1 Transcription Factor | 1 | 2016 | 17 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2016 | 21 | 0.140 |
Why?
|
| Cell-Derived Microparticles | 1 | 2016 | 7 | 0.140 |
Why?
|
| Microvessels | 1 | 2016 | 28 | 0.130 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 204 | 0.130 |
Why?
|
| Cell Adhesion Molecules | 1 | 2016 | 75 | 0.130 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2015 | 22 | 0.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 121 | 0.130 |
Why?
|
| Cytokines | 1 | 2019 | 602 | 0.130 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2015 | 28 | 0.130 |
Why?
|
| Serum Albumin, Bovine | 1 | 2015 | 51 | 0.130 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2006 | 26 | 0.130 |
Why?
|
| Mice, Nude | 1 | 2016 | 337 | 0.130 |
Why?
|
| Apoptosis | 2 | 2016 | 1398 | 0.130 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 127 | 0.130 |
Why?
|
| Endocytosis | 1 | 2015 | 113 | 0.120 |
Why?
|
| Endometriosis | 1 | 2016 | 73 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 1609 | 0.120 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 1371 | 0.120 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1198 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 539 | 0.110 |
Why?
|
| Membrane Proteins | 1 | 2016 | 517 | 0.100 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 409 | 0.100 |
Why?
|
| 3T3-L1 Cells | 1 | 2012 | 16 | 0.100 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 146 | 0.100 |
Why?
|
| Oligonucleotides | 1 | 2012 | 49 | 0.100 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 149 | 0.100 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 146 | 0.100 |
Why?
|
| Signal Transduction | 2 | 2019 | 1908 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 286 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2013 | 435 | 0.100 |
Why?
|
| RNA, Messenger | 1 | 2016 | 1207 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 218 | 0.100 |
Why?
|
| DNA, Mitochondrial | 1 | 2012 | 175 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 2379 | 0.090 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 4 | 1 | 2009 | 1 | 0.090 |
Why?
|
| Follicular Fluid | 1 | 2009 | 4 | 0.090 |
Why?
|
| Ovulation Induction | 1 | 2009 | 6 | 0.080 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2009 | 33 | 0.080 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2009 | 23 | 0.080 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 2 | 2006 | 4 | 0.080 |
Why?
|
| Carcinoma, Papillary | 1 | 2008 | 11 | 0.080 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2008 | 18 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2008 | 326 | 0.070 |
Why?
|
| Young Adult | 1 | 2016 | 4268 | 0.070 |
Why?
|
| Adolescent | 1 | 2016 | 5363 | 0.070 |
Why?
|
| Aged | 1 | 2016 | 6741 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 312 | 0.060 |
Why?
|
| Caveolins | 1 | 2004 | 8 | 0.060 |
Why?
|
| Adult | 2 | 2016 | 11712 | 0.060 |
Why?
|
| Serine | 1 | 2004 | 75 | 0.060 |
Why?
|
| Female | 4 | 2016 | 20969 | 0.060 |
Why?
|
| Cholesterol | 1 | 2004 | 205 | 0.050 |
Why?
|
| Middle Aged | 1 | 2016 | 10129 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 803 | 0.050 |
Why?
|
| Autocrine Communication | 1 | 2016 | 12 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2016 | 49 | 0.030 |
Why?
|
| Culture Media | 1 | 2016 | 90 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 2015 | 13 | 0.030 |
Why?
|
| Clathrin | 1 | 2015 | 21 | 0.030 |
Why?
|
| Lysosomes | 1 | 2015 | 91 | 0.030 |
Why?
|
| Cell Communication | 1 | 2015 | 97 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2015 | 93 | 0.030 |
Why?
|
| Tissue Preservation | 1 | 2013 | 7 | 0.030 |
Why?
|
| Rats, Transgenic | 1 | 2013 | 27 | 0.030 |
Why?
|
| Cryopreservation | 1 | 2013 | 25 | 0.030 |
Why?
|
| Protein Stability | 1 | 2013 | 45 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2015 | 384 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2013 | 103 | 0.030 |
Why?
|
| Temperature | 1 | 2013 | 286 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2013 | 389 | 0.030 |
Why?
|
| Embryo Transfer | 1 | 2009 | 33 | 0.020 |
Why?
|
| Fertilization in Vitro | 1 | 2009 | 54 | 0.020 |
Why?
|
| Staurosporine | 1 | 2008 | 38 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2008 | 62 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2008 | 33 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 1742 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2008 | 158 | 0.020 |
Why?
|
| Ovary | 1 | 2008 | 108 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 252 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 515 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2008 | 222 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 433 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2008 | 859 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 864 | 0.020 |
Why?
|
| Caveolae | 1 | 2004 | 9 | 0.020 |
Why?
|
| Caveolin 1 | 1 | 2004 | 29 | 0.010 |
Why?
|
| Anticholesteremic Agents | 1 | 2004 | 23 | 0.010 |
Why?
|
| Tyrosine | 1 | 2004 | 118 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2004 | 102 | 0.010 |
Why?
|
| Biological Transport | 1 | 2004 | 185 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 188 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2004 | 120 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 807 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 2231 | 0.010 |
Why?
|
| Peptides | 1 | 2004 | 320 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2004 | 928 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 972 | 0.010 |
Why?
|